Seel,Polkadot.Here is a post from Teedlum on the other
Seel,Polkadot.Here is a post from Teedlum on the other board.I have offered my shoulder and emotional support but there are questions that might best be answered by you.
As follows:
I need everyone's help. As some of you know, I had surgery last week and was waiting for the pathology report to come back. Well, I wish it was still pending. My doc told me I have a very rare cancer, the same type that Steve Jobs had. Technically, it is a high grade poorly differentiated neuroendocrine carcinoma . Worse yet, it has histologic grade of 3 and a mitotic rate of 27 per 10 high power fields. This is a very bad player and there's a 50/50 chance it has already metastasized. That will be determined by PET scan this next week. I will be staged after that. Depending on that data, my life expectancy is between 5 and 36 months. So much for reading Atlas Shrugged.
I have already been in touch with Leo and as you will not be surprised, he will be discussing it with Dr. Menon. Endocrine cancer is one of the cancers in the phase 1 trial for Kevetrin at Dana Farber . Wouldn't it be wonderfully ironic if the drug company in which I am heavily invested cures me?
However, I'm wondering, given the depth of research many of your do here, are any of you familiar with this cancer and aware of any other options? I have already identified a very exciting phase 1 that will be starting in Sweden with a college professor who has identified an adenovirus that "eats" neuroendocrine cancer . It destroyed the cancer in mice, but we all know mice are not necessarily men, unless your Steinbeck. See
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Testing the Waters with Education Stake Talk about mixing oil and water. Scienjoy Holding Corporation, those tech-savvy folks from China's live streaming circles, have set their sights on education with a hefty 29.9% stake in Leader Education Limited. For HK$102.69 million, that’s about US$13.1 million, they’re jumping into an industry with a different flavor....
Continue Reading
Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...
Continue Reading
Understanding Razor Bumps: More Than a Cosmetic Annoyance Crossing Great Neck this morning, I stumbled across a curious release from Laser by Aleya. Apparently, the problem with those pesky razor bumps plaguing many isn't just skin-deep. For some, especially those with coarse or curly hair, each razor stroke starts a relentless cycle of irritation that's as grinding as...
Continue Reading
New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...
Continue Reading
Amidst the hullabaloo of the reinsurance world, Corgi Insurance is attempting something rather bold. They're flinging open the doors to innovation with a new brainchild, Corgi Re, promising to shake off the dust from an industry that still clings to the bygone era of spreadsheets and marathon underwriting cycles. The aim? Fire up modern underwriting technology and...
Continue Reading
Qapture Investments just made a move in the digital finance space that's promising to turn some heads. From acquiring Flammarion Partners to snapping up Hermetik Trading's DeFi strategies, this Bermuda-based investment manager isn't here to play. Led by Frederick Pye, the firm's gearing up for an industry takeover by blending regulation with innovative digital finance...
Continue Reading
Straight up, a chance like this doesn't float by every day. The Guadalupe River portfolio, with its mix of entertainment, hospitality, and commercial assets up for grabs in New Braunfels, Texas, is the talk of the investor town. If you've got deep pockets and a keen eye for opportunities, you're gonna want a piece of this pie before the September 22 bid deadline hits. The...
Continue Reading
Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...
Continue Reading
Three Lions Joins the SPAC Playground The market's buzzing today as Three Lions Acquisition Corp. sauntered in with a $100M debut. Yep, they're the latest Special Purpose Acquisition Company out to net some big fish in the sports, hospitality, and real estate waters. A blank check company raising this kind of dough ain't exactly a novelty, but it never fails to turn a few...
Continue Reading
A Focus on Memory Preservation I remember a time when you kept memories in photo albums, dusty boxes in basements. Now, folks aim to digitize those moments before they're lost forever. With September here, Epson and The Photo Managers are telling us it's time for action. And hey, the campaign’s got a catchy name, 'One Photo, One Story.' Simple, yet it urges us all to...
Continue Reading
Top 5 Most Recently Viewed Articles
Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options Roche has recently made a remarkable advancement in the field of spinal muscular atrophy (SMA) treatment with the approval of the Evrysdi® tablet by the European Commission. This new formulation is not just another medication; it symbolizes a significant leap towards enhancing the quality of life for individuals...
Continue Reading
Introduction to the Global Cutting Fluid Market The cutting fluid market is on an exciting trajectory, anticipated to experience consistent growth over the next decade. It is estimated that the market will reach an impressive value of USD 16.3 billion by 2033, propelled by various factors that include industrial expansion and a growing preference for...
Continue Reading
IVX Health Honored by Modern Healthcare IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare for 2024. This esteemed honor reflects the company's commitment to excellence within the healthcare sector. The annual program highlights 150 distinguished organizations that excel in fostering a supportive and engaging workplace, and...
Continue Reading
New Board Leadership at the National Alliance on Mental Illness The National Alliance on Mental Illness (NAMI) has announced significant changes in its leadership to tackle the growing mental health crisis in the United States. This newly elected board for the 2025-2026 term comprises dedicated individuals with personal and community ties to mental health advocacy,...
Continue Reading
Overview of the Depression Treatment Market The depression treatment market is seeing a notable surge fueled by increasing mental health awareness and a rising number of individuals affected by this serious condition. With over 280 million people globally struggling with depression, the ongoing advancements in treatment options, including innovative antidepressants and...
Continue Reading